Search research articles
Contact Us
Filters
Showing results (111-120 of 118) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 118 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 26, 2024
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial
Christian Marth, Richard G Moore, Mariusz Bidziński, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 21, 2026
Lenvatinib plus pembrolizumab in participants with advanced or recurrent endometrial cancer: Study 309/KEYNOTE-775 and ENGOT-en9/LEAP-001 post-(neo)adjuvant therapy outcomes
Christian Marth, Domenica Lorusso, Mariusz Bidziński, et al.
The New England Journal of Medicine
|
March 27, 2023
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Ramez N Eskander, Michael W Sill, Lindsey Beffa, et al.
The New England Journal of Medicine
|
September 29, 2019
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Antonio González-Martín, Bhavana Pothuri, Ignace Vergote, et al.
Nature Medicine
|
March 5, 2025
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial
Ramez N Eskander, Michael W Sill, Lindsey Beffa, et al.
Journal of Medicinal Chemistry
|
April 11, 2022
Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors <i>In Vivo</i>
Negar Khazan, Kyu Kwang Kim, Jeanne N Hansen, et al.
Gynecologic Oncology
|
July 1, 2026
Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer
Mark S Shahin, Domenica Lorusso, Floor J Backes, et al.
Cancers
|
July 14, 2023
Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1
Negar Khazan, Emily R Quarato, Niloy A Singh, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 118) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 118 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 26, 2024
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial
Christian Marth, Richard G Moore, Mariusz Bidziński, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 21, 2026
Lenvatinib plus pembrolizumab in participants with advanced or recurrent endometrial cancer: Study 309/KEYNOTE-775 and ENGOT-en9/LEAP-001 post-(neo)adjuvant therapy outcomes
Christian Marth, Domenica Lorusso, Mariusz Bidziński, et al.
The New England Journal of Medicine
|
March 27, 2023
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Ramez N Eskander, Michael W Sill, Lindsey Beffa, et al.
The New England Journal of Medicine
|
September 29, 2019
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Antonio González-Martín, Bhavana Pothuri, Ignace Vergote, et al.
Nature Medicine
|
March 5, 2025
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial
Ramez N Eskander, Michael W Sill, Lindsey Beffa, et al.
Journal of Medicinal Chemistry
|
April 11, 2022
Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors <i>In Vivo</i>
Negar Khazan, Kyu Kwang Kim, Jeanne N Hansen, et al.
Gynecologic Oncology
|
July 1, 2026
Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer
Mark S Shahin, Domenica Lorusso, Floor J Backes, et al.
Cancers
|
July 14, 2023
Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1
Negar Khazan, Emily R Quarato, Niloy A Singh, et al.
Page
of 12